Positions

Overview

  • Dr Rogers received his AB degree in Biochemistry from Princeton University and MD degree from Johns Hopkins University School of Medicine. He did internal medicine residency at the Johns Hopkins Hospital, served two years in the U. S. Army Medical Corps in Vietnam and in El Paso, Texas, and then completed a fellowship in Cardiology at the University of Alabama Medical Center in 1975. He has since remained at UAB, has been Professor of Medicine since 1984 and served as Director of the Coronary Care Unit at University of Alabama Hospital for 27 years. He has been Principal Investigator for UAB for many pivotal collaborative clinical trials in cardiology including CASS, CAST, SOLVD, HERS, WISE, WAVE and multiple TIMI trials. He has been active in patient care and selected by peers on the Best Doctors in America List annually for 15 years.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trialLancet Diabetes and Endocrinology.  7:618-628. 2019
    2018 Alirocumab and cardiovascular outcomes after acute coronary syndromeNew England Journal of Medicine.  379:2097-2107. 2018
    2018 Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trialLancet.  392:2269-2279. 2018
    2017 Ten-Year Mortality in the WISE Study (Women's Ischemia Syndrome Evaluation)Circulation: Cardiovascular Quality and Outcomes.  10. 2017
    2017 Effects of anacetrapib in patients with atherosclerotic vascular diseaseNew England Journal of Medicine.  377:1217-1227. 2017
    2017 Sudden cardiac death in women with suspected Ischemic Heart Disease, Preserved ejection fraction, and no obstructive coronary artery disease: A report from the Women's Ischemia Syndrome Evaluation StudyJournal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.  6. 2017
    2017 Aortic flow conditions predict ejection efficiency in the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE)Cardiovascular diagnosis and therapy.  7:288-295. 2017
    2017 Evolocumab and clinical outcomes in patients with cardiovascular diseaseNew England Journal of Medicine.  376:1713-1722. 2017
    2017 SYNTAX Score and Long-Term Outcomes: The BARI-2D TrialJournal of the American College of Cardiology.  69:395-403. 2017
    2017 OPTIMAL METHOD FOR ANGIOGRAPHIC DEFINITION AND QUANTIFICATION OF REGIONAL LEFT VENTRICULAR CONTRACTION.Computers in Cardiology.  293-296. 2017
    2016 Use of bio-informatics assessment schema (BIAS) to improve diagnosis and prognosis of myocardial perfusion data: Results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE)Cardiovascular diagnosis and therapy.  6:424-431. 2016
    2016 Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary SyndromeJournal of Women's Health.  25:875-881. 2016
    2015 Ezetimibe added to statin therapy after acute coronary syndromesNew England Journal of Medicine.  372:2387-2397. 2015
    2015 Sex, prescribing practices and guideline recommended, blood pressure, and LDL cholesterol targets at baseline in the BARI 2D trialInternational Journal of Endocrinology.  2015. 2015
    2014 Effect of darapladib on major coronary events after an acute coronary syndrome: The SOLID-TIMI 52 randomized clinical trialJournal of the American Medical Association.  312:1006-1015. 2014
    2014 Effect of evolocumab or ezetimibe added to moderate- Or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: The LAPLACE-2 randomized clinical trialJournal of the American Medical Association.  311:1870-1882. 2014
    2014 Rationale and design of LAPLACE-2: A phase 3, randomized, double-blind, placebo- and ezetimibe-controlled trial evaluating the efficacy and safety of evolocumab in subjects with hypercholesterolemia on background statin therapyClinical Cardiology.  37:195-203. 2014
    2013 Improved diagnosis and prognosis using Decisions Informed by Combining Entities (DICE): results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).Cardiovascular diagnosis and therapy.  3:216-227. 2013
    2013 AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: An analysis from the LDL-C assessment with proprotein convertase subtilisin kexin type 9 monoclonal antibody inhibition combined with statin therapy (LAPLACE)-thrombolysis in myocardial infarction (TIMI) 57 TrialCirculation.  128:962-969. 2013
    2013 Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: Insights from the SOLVD Treatment trialInternational Journal of Cardiology.  167:151-156. 2013
    2013 Left Ventricular Energy Model Predicts Adverse Events in Women With Suspected Myocardial Ischemia: Results From The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study.Cardiovascular diagnosis and therapy.  3:64-72. 2013
    2013 Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: A report from the BARI 2D trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes)Journal of the American College of Cardiology.  61:1767-1776. 2013
    2012 Diabetes mellitus and trends in hospital survival after myocardial infarction, 1994 to 2006: Data from the national registry of myocardial infarctionCirculation: Cardiovascular Quality and Outcomes.  5:791-797. 2012
    2012 Clinical and angiographic risk stratification and differential impact on treatment outcomes in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trialCirculation.  126:2115-2124. 2012
    2012 Prasugrel versus clopidogrel for acute coronary syndromes without revascularizationNew England Journal of Medicine.  367:1297-1309. 2012
    2012 Atherosclerotic risk factors and their association with hospital mortality among patients with first myocardial infarction (from the national registry of myocardial infarction)American Journal of Cardiology.  110:1256-1261. 2012
    2012 Vorapaxar in the secondary prevention of atherothrombotic eventsNew England Journal of Medicine.  366:1404-1413. 2012
    2012 Differences in symptom presentation and hospital mortality according to type of acute myocardial infarctionAmerican Heart Journal.  163:572-579. 2012
    2012 Association of age and sex with myocardial infarction symptom presentation and in-hospital mortalityJournal of the American Medical Association.  307:813-822. 2012
    2012 Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): A randomised, placebo-controlled, dose-ranging, phase 2 studyLancet.  380:2007-2017. 2012
    2011 Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular diseaseJournal of the American Medical Association.  306:2221-2228. 2011
    2011 Number of coronary heart disease risk factors and mortality in patients with first myocardial infarctionJournal of the American Medical Association.  306:2120-2127. 2011
    2011 High risk closure of a large secundum ASD causing platypnea-orthodeoxiaInternational Journal of Cardiology.  152. 2011
    2011 Body mass index and health status in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial (BARI 2D)American Heart Journal.  162. 2011
    2010 Relationships of obesity and fat distribution with atherothrombotic risk factors: Baseline results from the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trialObesity Research.  18:1046-1054. 2010
    2010 The effect of obesity on quality of life in patients with diabetes and coronary artery diseaseAmerican Heart Journal.  159:292-300. 2010
    2010 A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: Results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)American Heart Journal.  159:987.e1-987.e7. 2010
    2010 Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.JACC: Cardiovascular Imaging.  3:1030-1036. 2010
    2009 Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the bypass angioplasty revascularization investigation 2 diabetes trialCirculation.  120:2550-2558. 2009
    2009 Sex differences in mortality after acute myocardial infarction: Changes from 1994 to 2006Archives of Internal Medicine -New Series-.  169:1767-1774. 2009
    2009 The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia. A Report From the Women's Ischemia Syndrome Evaluation (WISE)American Heart Journal.  157:548-555. 2009
    2008 Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006American Heart Journal.  156:1026-1034. 2008
    2008 Trends in quality of care for patients with acute myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006American Heart Journal.  156:1045-1055. 2008
    2008 Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006American Heart Journal.  156:1035-1044. 2008
    2008 Importance of socioeconomic status as a predictor of cardiovascular outcome and costs of care in women with suspected myocardial ischemia. Results from the national institutes of health, national heart, lung and blood institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)Journal of Women's Health.  17:1081-1092. 2008
    2008 Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?Journal of Women's Health.  17:841-847. 2008
    2008 Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: Results from the National Institutes of Health - National Heart, Lung, and Blood Institute sponsored women's ischemia syndrome evaluationJournal of Clinical Endocrinology and Metabolism.  93:1276-1284. 2008
    2007 Phytoestrogens and coronary microvascular function in women with suspected myocardial ischemia: A report from the Women's Ischemia Syndrome Evaluation (WISE) studyJournal of Women's Health.  16:481-488. 2007
    2006 Effectiveness and Safety of Glycoprotein IIb/IIIa Inhibitors and Clopidogrel Alone and in Combination in Non-ST-Segment Elevation Myocardial Infarction (from the National Registry of Myocardial Infarction-4)American Journal of Cardiology.  98:1125-1131. 2006
    2006 Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: The NHLBI-Sponsored WISE StudyArchives of General Psychiatry.  63:874-880. 2006
    2006 The economic burden of angina in women with suspected ischemic heart disease: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome EvaluationCirculation.  114:894-904. 2006
    2006 Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: Results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) studyEuropean Heart Journal.  27:1408-1415. 2006
    2006 Depression is associated with cardiac symptoms, mortality risk, and hospitalization among women with suspected coronary disease: The NHLBI-sponsored WISE studyPsychosomatic Medicine.  68:217-223. 2006
    2006 Hypertension, menopause, and coronary artery disease risk in the Women's Ischemia Syndrome Evaluation (WISE) studyJournal of the American College of Cardiology.  47:S50-S58. 2006
    2006 Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Part I: Gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategiesJournal of the American College of Cardiology.  47:S4-S20. 2006
    2006 Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Part II: Gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary diseaseJournal of the American College of Cardiology.  47:S21-S29. 2006
    2006 The value of estimated functional capacity in estimating outcome: Results from the NHBLI-sponsored Women's Ischemia Syndrome Evaluation (WISE) studyJournal of the American College of Cardiology.  47:S36-S43. 2006
    2005 Quality of care by classification of myocardial infarction. Treatment patterns for ST-segment elevation vs non-ST-segment elevation myocardial infarctionArchives of Internal Medicine -New Series-.  165:1630-1636. 2005
    2005 Hostility scores are associated with increased risk of cardiovascular events in women undergoing coronary angiography: A report from the NHLBI-sponsored WISE studyPsychosomatic Medicine.  67:546-552. 2005
    2005 Inflammation, endothelial cell activation, and coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery diseaseAmerican Heart Journal.  150:109-115. 2005
    2005 Azithromycin for the secondary prevention of coronary eventsNew England Journal of Medicine.  352:1637-1645. 2005
    2005 Pulse pressure and coronary atherosclerosis progression in postmenopausal womenHypertension.  45:53-57. 2005
    2004 Social networks are associated with lower mortality rates among women with suspected coronary disease: The national heart, lung, and blood institute-sponsored women's ischemia syndrome evaluation studyPsychosomatic Medicine.  66:882-888. 2004
    2004 Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery diseaseCirculation.  110:1960-1966. 2004
    2004 Relation of age and race with hospital death after acute myocardial infarctionAmerican Heart Journal.  148:92-98. 2004
    2004 Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)Circulation.  109:2993-2999. 2004
    2004 Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: Results from the National Heart, Lung, and Blood Institute women's ischemia syndrome evaluation studyJournal of the American College of Cardiology.  43:2009-2014. 2004
    2004 Validation of the accuracy of pretest and exercise test scores in women with a low prevalence of coronary disease: The NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) studyAmerican Heart Journal.  147:1085-1092. 2004
    2004 Large scale association analysis for identification of genes underlying premature coronary heart disease: Cumulative perspective from analysis of 111 candidate genesJournal of Medical Genetics.  41:334-341. 2004
    2004 Clinical Importance of Obesity Versus the Metabolic Syndrome in Cardiovascular Risk in Women: A Report from the Women's Ischemia Syndrome Evaluation (WISE) StudyCirculation.  109:706-713. 2004
    2004 Does Initial and Delayed Heart Rate Predict Mortality in Patients with Acute Coronary Syndromes?Clinical Cardiology.  27:80-86. 2004
    2004 Premature Myocardial Infarction Novel Susceptibility Locus on Chromosome 1P34-36 Identified by Genomewide Linkage AnalysisAmerican Journal of Human Genetics.  74:262-271. 2004
    2003 Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patientsHuman Genetics.  114:87-98. 2003
    2003 The impact of myocardial flow reserve on the detection of coronary artery disease by perfusion imaging methods: An NHLBI WISE studyJournal of Cardiovascular Magnetic Resonance.  5:475-485. 2003
    2003 Association of genetic variants in the HDL receptor, SR-B1, with abnormal lipids in women with coronary artery diseaseJournal of Medical Genetics.  40:453-458. 2003
    2003 Effect of postmenopausal hormone therapy on coronary heart disease events after percutaneous transluminal coronary angioplastyAmerican Journal of Cardiology.  91:989-991. 2003
    2003 Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: A randomized control trialEvidence Based Eye Care.  4:82-83. 2003
    2003 Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: A report from the NHLBI-sponsored WISE studyJournal of the American College of Cardiology.  41:413-419. 2003
    2003 Failure of benefit and early hazard of bucindolol for Class IV heart failureJournal of Cardiac Failure.  9:266-277. 2003
    2003 Socioeconomic Status Variables Predict Cardiovascular Disease Risk Factors and Prospective Mortality Risk among Women with Chest Pain: The WISE StudyBehavior Modification.  27:54-67. 2003
    2002 Use of emergency medical services in acute myocardial infarction and subsequent quality of care: Observations from the national registry of myocardial infarction 2Circulation.  106:3018-3023. 2002
    2002 Electrocardiogram abnormalities predict angiographic coronary artery disease in women with chest pain: Results from the NHLBI WISE studyClinical Cardiology.  25:553-558. 2002
    2002 Women's Angiographic Vitamin and Estrogen trial: Design and methodsControlled Clinical Trials.  23:708-727. 2002
    2002 Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: A randomized controlled trialJournal of the American Medical Association.  288:2432-2440. 2002
    2002 Predictors of mortality, coronary angiography, and revascularization in unstable angina pectoris and acute non-ST elevation myocardial infarction (the TIMI III registry)American Journal of Cardiology.  90:1154-1156. 2002
    2002 Safety and effectiveness of combined low molecular weight heparin and glycoprotein IIb/IIIa inhibitorsAmerican Journal of Cardiology.  90:911-915. 2002
    2002 Prognosis in the Thrombolysis in Myocardial Ischemia III Registry according to the Braunwald unstable angina pectoris classificationAmerican Journal of Cardiology.  90:821-826. 2002
    2002 Mild renal insufficiency is associated with angiographic coronary artery disease in womenCirculation.  105:2826-2829. 2002
    2002 Payer status and the utilization of hospital resources in acute myocardial infarctionArchives of Internal Medicine -New Series-.  160:817-823. 2002
    2002 Large brachial artery diameter is associated with angiographic coronary artery disease in womenAmerican Heart Journal.  143:802-807. 2002
    2002 The association of sex and payer status on management and subsequent survival in acute myocardial infarctionArchives of Internal Medicine -New Series-.  162:587-593. 2002
    2001 Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarctionCirculation.  104:2641-2644. 2001
    2001 Diagnostic, prognostic, and cost assessment of coronary artery disease in womenAmerican Journal of Managed Care.  7:959-965. 2001
    2001 Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] study angiographic core laboratory)American Journal of Cardiology.  87:937-941. 2001
    2001 History of anxiety disorders is associated with a decreased likelihood of angiographic coronary artery disease in women with chest pain: The WISE studyJournal of the American College of Cardiology.  37:780-785. 2001
    2001 Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: Results from the NHLBI WISE studyAmerican Heart Journal.  141:735-741. 2001
    2001 Psychosocial variables are associated with atherosclerosis risk factors among women with chest pain: The WISE studyPsychosomatic Medicine.  63:282-288. 2001
    2001 Underutilization of reperfusion therapy in eligible African Americans with acute myocardial infarction: Role of presentation and evaluation characteristicsAmerican Heart Journal.  142:604-610. 2001
    2000 Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999: The National Registry of Myocardial Infarction 1, 2 and 3Journal of the American College of Cardiology.  36:2056-2063. 2000
    2000 The volume of primary angioplasty procedures and survival after acute myocardial infarction [4] (multiple letters)New England Journal of Medicine.  343:1045. 2000
    2000 Effects of estrogen replacement on the progression of coronary-artery atherosclerosisNew England Journal of Medicine.  343:522-529. 2000
    2000 Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest painJournal of the American Medical Association.  283:3223-3229. 2000
    2000 Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarctionJournal of the American Medical Association.  283:2941-2947. 2000
    2000 The volume of primary angioplasty procedures and survival after acute myocardial infarctionNew England Journal of Medicine.  342:1573-1580. 2000
    2000 Effect of coronary angiography on use of lipid-lowering agents in women: A report from the women's ischemia syndrome evaluation (WISE) studyAmerican Journal of Cardiology.  85:1083-1088. 2000
    2000 Payer status and the utilization of hospital resources in acute myocardial infarction: a report from the National Registry of Myocardial Infarction 2.Archives of Internal Medicine -New Series-.  160:817-823. 2000
    2000 Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiogramsNew England Journal of Medicine.  342:829-835. 2000
    2000 Treatment and outcome of myocardial infarction in hospitals with and without invasive capabilityJournal of the American College of Cardiology.  35:371-379. 2000
    2000 Quality of life after coronary revascularization in the United States and CanadaAmerican Journal of Cardiology.  85:548-553. 2000
    2000 Early and pre-discharge aspirin administration among patients with acute myocardial infarction: Current clinical practice and trends in the United StatesJournal of Thrombosis and Thrombolysis.  9:207-215. 2000
    2000 Intravenous NPA for the treatment of infarcting myocardium early: InTIME-II, a double-blind comparison on of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarctionEuropean Heart Journal.  21:2005-2013. 2000
    1999 Reperfusion therapy in patients with acute myocardial infarction and prior coronary artery bypass graft surgery (National Registry of Myocardial Infarction-2)American Journal of Cardiology.  84:1287-1291. 1999
    1999 The association between the on-site availability of cardiac procedures and the utilization of those services for acute myocardial infarction by payer group. The National Registry of Myocardial Infarction 2 Investigators.Clinical Cardiology.  22:519-524. 1999
    1999 Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) studyJournal of the American College of Cardiology.  33:1469-1475. 1999
    1999 Dobutamine stress echocardiography in women with chest pain. Pilot phase data from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE)Journal of the American College of Cardiology.  33:1462-1468. 1999
    1999 The Women's Ischemia Syndrome Evaluation (WISE) study: Protocol design, methodology and feasibility reportJournal of the American College of Cardiology.  33:1453-1461. 1999
    1999 Clinical correlates of the initial and long-term cost of coronary bypass surgery and coronary angioplastyAmerican Heart Journal.  138:376-383. 1999
    1999 Comparison of outcomes research with clinical trials using preexisting dataAmerican Journal of Cardiology.  84:923-927. 1999
    1999 Consultation before thrombolytic therapy in acute myocardial infarctionAmerican Journal of Cardiology.  83:89-93. 1999
    1999 The association between the on-site availability of cardiac procedures and the utilization of those services for acute myocardial infarction by payer groupClinical Cardiology.  22:519-524. 1999
    1998 Management and outcomes for black patients with acute myocardial infarction in the reperfusion eraAmerican Journal of Cardiology.  82:1019-1023. 1998
    1998 Presenting characteristics, treatment patterns, and clinical outcomes of non-black minorities in the national registry of myocardial infarction 2American Journal of Cardiology.  82:1013-1018. 1998
    1998 Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarctionAnnals of Internal Medicine.  129:597-604. 1998
    1998 Employment after coronary angioplasty or coronary bypass surgery in patients employed at the time of revascularizationAnnals of Internal Medicine.  129:543-547. 1998
    1998 Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (the second national registry of myocardial infarction)American Journal of Cardiology.  82:259-264. 1998
    1998 Influence of payor on use of invasive cardiac procedures and patient outcome after myocardial infarction in the United StatesJournal of the American College of Cardiology.  31:1474-1480. 1998
    1998 Observations of the treatment of women in the United States with myocardial infarction: A report from the National Registry of Myocardial Infarction-IArchives of Internal Medicine -New Series-.  158:981-988. 1998
    1998 Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (Recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: A report from the Second National Registry of Myocardial Infarction (NRMI-2)Journal of the American College of Cardiology.  31:1240-1245. 1998
    1998 Use of reperfusion therapy for acute myocardial infarction in the United States: Data from the National Registry of Myocardial Infarction 2Circulation.  97:1150-1156. 1998
    1998 Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: A nationwide perspective of current clinical practiceAmerican Heart Journal.  135:786-796. 1998
    1998 Relation of coagulation parameters to patency and recurrent ischemia in the Thrombolysis in Myocardial Infarction (TIMI) Phase II TrialAmerican Heart Journal.  135:29-37. 1998
    1997 Factors influencing the time to thrombolysis in acute myocardial infarctionArchives of Internal Medicine -New Series-.  157:2577-2582. 1997
    1997 Cognitive function 5 years after randomization to coronary angioplasty or coronary artery bypass graft surgeryCirculation.  96. 1997
    1997 Myocardial infarction and cardiac mortality in the bypass angioplasty revascularization investigation (BARI) randomized trialCirculation.  96:2162-2170. 1997
    1997 Relation between clinical, angiographic and ischemic findings at baseline and ischemia-related adverse outcomes at 1 year in the asymptomatic cardiac ischemia pilot studyJournal of the American College of Cardiology.  29:1483-1489. 1997
    1997 The prehospital electrocardiogram in acute myocardial infarction: Is its full potential being realized?Journal of the American College of Cardiology.  29:498-505. 1997
    1997 Long-term survival of African Americans in the Coronary Artery Surgery Study (CASS)Journal of the American College of Cardiology.  29:358-364. 1997
    1997 Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgeryNew England Journal of Medicine.  336:92-99. 1997
    1997 Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction: The TIMI-II pilot and randomized clinical trial combined experienceStroke.  28:1107-1114. 1997
    1997 The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: Results of the TIMI III registry ECG ancillary studyJournal of the American College of Cardiology.  30:133-140. 1997
    1996 Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease: The Bypass Angioplasty Revascularization Investigation (BARI) investigatorsNew England Journal of Medicine.  335:217-225. 1996
    1996 Relation of patient characteristics to cardiac ischemia during daily life activity (an Asymptomatic Cardiac Ischemia Pilot data bank study)American Journal of Cardiology.  77:1267-1272. 1996
    1996 Asymptomatic Cardiac Ischemia Pilot (ACIP) study: What clinical implications does it have? [2]Journal of the American College of Cardiology.  27:1316-1318. 1996
    1996 Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registryJournal of the American Medical Association.  275:1104-1112. 1996
    1996 Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarctionAnnals of Internal Medicine.  124:283-291. 1996
    1996 A composite view of cardiac rupture in the United States National Registry of Myocardial InfarctionJournal of the American College of Cardiology.  27:1321-1326. 1996
    1996 Asymptomatic cardiac ischemia pilot (ACIP) study: Relationship between exercise-induced and ambulatory ischemia in patients with stable coronary diseaseCirculation.  94:1537-1544. 1996
    1996 Comparison of outcome of patients with unstable angina and non-Q-wave acute myocardial infarction with and without prior coronary artery bypass grafting (Thrombolysis in Myocardial Ischemia III Registry)American Journal of Cardiology.  77:227-231. 1996
    1996 Hospital protocols and policies that may delay early identification and thrombolytic therapy of acute myocardial infarction patientsJournal of Thrombosis and Thrombolysis.  3:301-306. 1996
    1996 Pre-hospital electrocardiogram in the second national registry of myocardial infarction (NRMI-2)Journal of Investigative Medicine.  44. 1996
    1995 Asymptomatic cardiac ischemia pilot (ACIP) study: Improvement of cardiac ischemia at 1 year after PTCA and CABGCirculation.  92. 1995
    1995 Factors influencing the time to administration of thrombolytic therapy with recombinant tissue plasminogen activator (data from the national registry of myocardial infarction)American Journal of Cardiology.  76:548-552. 1995
    1995 Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis: Results from the TIMI II studyCirculation.  91:2541-2548. 1995
    1995 Bypass Angioplasty Revascularization Investigation (BARI): baseline clinical and angiographic data.American Journal of Cardiology.  75:9C-17C. 1995
    1995 Association between body weight and in-hospital clinical outcome following thrombolytic therapy: A report from the national registry of myocardial infarctionJournal of Thrombosis and Thrombolysis.  2:231-237. 1995
    1995 Asymptomatic cardiac ischemia pilot (ACIP) study: Effects of coronary angioplasty and coronary artery bypass graft surgery on recurrent angina and ischemiaJournal of the American College of Cardiology.  26:606-614. 1995
    1995 Asymptomatic cardiac ischemia pilot (ACIP) study: Impact of anti-ischemia therapy on 12-week rest electrocardiogram and exercise test outcomesJournal of the American College of Cardiology.  26:585-593. 1995
    1995 Asymptomatic cardiac ischemia pilot (ACIP) study: Outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularizationJournal of the American College of Cardiology.  26:594-605. 1995
    1995 Better functional status in American than Canadian patients with heart disease: An effect of medical care?Journal of the American College of Cardiology.  26:1115-1120. 1995
    1995 Bypass Angioplasty Revascularization Investigation (BARI): Baseline clinical and angiographic dataAmerican Journal of Cardiology.  75:C9-C17. 1995
    1995 Contemporary management of acute myocardial infarctionAmerican Journal of Medicine.  99:195-206. 1995
    1995 Recurrence of angina after coronary artery bypass surgery: Predictors and prognosis (CASS registry)Journal of the American College of Cardiology.  26:895-899. 1995
    1994 Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction.Circulation.  90:2103-2114. 1994
    1994 What is the optimal tool to define appropriate therapy: The randomized clinical trial, meta-analysis, or outcomes research?Current Opinion in Cardiology.  9:401-403. 1994
    1994 Comparison of primary angioplasty versus thrombolytic therapy for acute myocardial infarctionAmerican Journal of Cardiology.  74:111-118. 1994
    1994 Effect on outcome of the presence or absence of chest pain at initiation of recombinant tissue plasminogen activator therapy in acute myocardial infarctionAmerican Journal of Cardiology.  73:729-736. 1994
    1994 In Reply: The Predictive Capabilities of Clinical Tests: The 6-Minute WalkJournal of the American Medical Association.  271:662. 1994
    1994 A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trialJournal of the American College of Cardiology.  23:993-1003. 1994
    1994 Clinical trials in thrombolysis, revisited: OverviewCoronary Artery Disease.  5:279-281. 1994
    1994 Dose-response study of intravenous torsemide in congestive heart failureAmerican Heart Journal.  128:352-357. 1994
    1994 Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-Week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) studyJournal of the American College of Cardiology.  24:11-20. 1994
    1994 Patient perception of a long-term clinical trial: Experience using a close-out questionnaire in the studies of left ventricular dysfunction (SOLVD) trialControlled Clinical Trials.  15:284-293. 1994
    1994 Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: The studies of left ventricular dysfunctionJournal of the American College of Cardiology.  23:393-400. 1994
    1994 The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: Design of a randomized clinical trial, baseline data and implications for a long-term outcome trialJournal of the American College of Cardiology.  24:1-10. 1994
    1994 Treatment of myocardial infarction in the United States (1990 to 1993): Observations from the National Registry of Myocardial InfarctionCirculation.  90:2103-2114. 1994
    1993 Mortality Following Ventricular Arrhythmia Suppression by Encainide, Flecainide, and Moricizine After Myocardial Infarction: The Original Design Concept of the Cardiac Arrhythmia Suppression Trial (CAST)Journal of the American Medical Association.  270:2451-2455. 1993
    1993 Prediction of Mortality and Morbidity With a 6-Minute Walk Test in Patients With Left Ventricular DysfunctionJournal of the American Medical Association.  270:1702-1707. 1993
    1993 Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators.Journal of the American Medical Association.  270:1702-1707. 1993
    1993 Race and prognosis after myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial.Circulation.  88:1484-1494. 1993
    1993 Ischemic heart diseaseCurrent Opinion in Cardiology.  8:553-556. 1993
    1993 Race and prognosis after myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II trialCirculation.  88:1484-1494. 1993
    1992 Renal, hemodynamic, and electrocardiographic effects of low versus high osmolality contrast agents on the transplanted heart.The Journal of heart transplantation.  11:584-586. 1992
    1992 Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery: A report from the Coronary Artery Surgery Study (CASS) registryCirculation.  86:446-457. 1992
    1992 Effect of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the coronary artery surgery study (CASS): 10-Year follow-upJournal of the American College of Cardiology.  20:287-294. 1992
    1992 Ischemic heart diseaseCurrent Opinion in Cardiology.  7:537-540. 1992
    1992 OverviewCoronary Artery Disease.  3:89-91. 1992
    1992 Prognostic significance of ventricular premature depolarizations measured 1 year after myocardial infraction in patient with early postinfarction asymptomatic ventricular arrhythmiaJournal of the American College of Cardiology.  20:259-264. 1992
    1992 Renal, hemodynamic, and electrocardiographic effects of low versus high osmolality contrast agents on the transplanted heartThe Journal of heart transplantation.  11:584-586. 1992
    1991 Initial blood pressure response to enalapril in hospitalized patients (studies of left ventricular dysfunction [SOLVD])American Journal of Cardiology.  68:1465-1468. 1991
    1991 Long-term effect of thrombolytic therapy on left ventricular ejection fraction after acute myocardial infarctionAmerican Journal of Cardiology.  67:1354-1359. 1991
    1991 Coronary angiography after thrombolytic therapy for acute myocardial infarctionAnnals of Internal Medicine.  114:877-885. 1991
    1991 Early tPA Treatment and Aeromedical Transport of Patients with Acute Myocardial InfarctionJournal of Interventional Cardiology.  4:81-89. 1991
    1991 ISIS-3: Implications for American practiceCardiovascular Reviews and Reports.  12:37-44+49. 1991
    1991 Immediate versus deferred β-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) II-B studyCirculation.  83:422-437. 1991
    1991 Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarctionJournal of the American College of Cardiology.  17:1007-1016. 1991
    1990 Heparin and infarct coronary artery patency after streptokinase in acute myocardial infarctionAmerican Journal of Cardiology.  65:967-972. 1990
    1990 Coagulation and fibrinolytic changes in evolving acute myocardial infarction treated by high-dose, brief-duration intracoronary or intravenous streptokinaseAmerican Journal of Clinical Pathology.  93:246-251. 1990
    1990 Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator: Results of the thrombolysis in myocardial infarction (TIMI) phase II-A trialCirculation.  81:1457-1476. 1990
    1990 Coronary angioplasty in acute MI. Part 1.Alabama medicine : journal of the Medical Association of the State of Alabama.  59:32-34. 1990
    1990 Coronary angioplasty in acute MI. Part 2.Alabama medicine : journal of the Medical Association of the State of Alabama.  59. 1990
    1990 Significance of ventricular tachyarrhythmias complicating cardiac catheterization: A CASS Registry studyAmerican Heart Journal.  119:494-502. 1990
    1990 Ten-year follow-up of quality of life in patients randomized to receive medical therapy or coronary artery bypass graft surgery. The Coronary Artery Surgery Study (CASS)Circulation.  82:1647-1658. 1990
    1990 The thrombolysis in myocardial infarction (TIMI) Trial Phase II: Additional information and perspectivesJournal of the American College of Cardiology.  15:1188-1192. 1990
    1989 Variables predictive of good functional outcome following thrombolytic therapy in the Thrombolysis in Myocardial Infarction phase II (TIMI II) pilot studyAmerican Journal of Cardiology.  63:503-512. 1989
    1989 Asymptomatic left main coronary artery disease in the Coronary Artery Surgery Study (CASS) registryCirculation.  79:1171-1179. 1989
    1989 Coronary artery to right ventricle fistula in heart transplant recipients: A complication of endomyocardial biopsyJournal of the American College of Cardiology.  14:258-261. 1989
    1988 Comparison of effects of medical and surgical therapy on survival in severe angina pectoris and two-vessel coronary artery disease with and without left ventricular dysfunction: A coronary artery surgery study registry studyAmerican Journal of Cardiology.  61:1198-1203. 1988
    1987 Thrombolytic therapy in acute myocardial infarction.The Alabama journal of medical sciences.  24:183-190. 1987
    1987 Morphology of occlusive coronary lesions during acute myocardial infarction: An angiographic and clinical analysisAmerican Heart Journal.  113:84-89. 1987
    1987 The thrombolysis in myocardial infarction (TIMI) phase II pilot study: Tissue plasminogen activator followed by percutaneous transluminal coronary angioplastyJournal of the American College of Cardiology.  10:51B-64B. 1987
    1986 Energy dependent insulin binding, internalization and degradation in isolated cardiac myocytes from normal and diabetic ratsJournal of Molecular and Cellular Cardiology.  18:157-168. 1986
    1986 The assessment of contractile reserve after thrombolytic therapy for acute myocardial infarctionAmerican Heart Journal.  111:821-825. 1986
    1985 Collateral flow in patients with acute myocardial infarctionAmerican Journal of Cardiology.  56:729-736. 1985
    1985 Medical vs. surgical management of ischemic heart disease. Implications of the coronary artery surgery study.The Alabama journal of medical sciences.  22:416-422. 1985
    1985 Intermediate-term results of coronary artery bypass grafting for acute myocardial infarction.Circulation.  72. 1985
    1985 Improved myocardial contractility with glucose-insulin-potassium infusion during pacing in coronary artery diseaseAmerican Journal of Cardiology.  55:932-936. 1985
    1985 The measurement of fibrinogen by the DuPont aca® and Dade® methods in patients receiving streptokinase infusionsAmerican Journal of Clinical Pathology.  84:526-529. 1985
    1985 The plights of the invasive treatment of ischemic heart diseaseJournal of the American College of Cardiology.  5:158-167. 1985
    1984 Oral Levodopa in Heart FailureNew England Journal of Medicine.  311:671-672. 1984
    1984 Surgical treatment of acute myocardial infarction.The Alabama journal of medical sciences.  21:175-177. 1984
    1984 Evaluation of a QRS scoring system for estimating myocardial infarct size. IV. Correlation with quantitative anatomic findings for posterolateral infarctsAmerican Journal of Cardiology.  53:706-714. 1984
    1984 Direct effects of streptokinase on the isolated rat myocardiumJournal of Cardiovascular Pharmacology.  6:1120-1123. 1984
    1984 Isolation and characterization of β1-adrenergic receptors from adult, rat cardiac myocytesJournal of Molecular and Cellular Cardiology.  16:867-873. 1984
    1984 Return of left ventricular function after reperfusion in patients with myocardial infarction: Importance of subtotal stenoses or intact collateralsCirculation.  69:338-349. 1984
    1984 Use of beta blockers in the treatment of ischemic heart disease: A comparison of the available agentsCardiovascular Reviews and Reports.  5:31-43. 1984
    1983 Platelet function abnormalities in response to arachidonic acid in the acute phase of myocardial infarctionAmerican Journal of Cardiology.  52:965-968. 1983
    1983 ReplyAmerican Journal of Cardiology.  51:1566. 1983
    1983 The financial pain of chest discomfort.The Alabama journal of medical sciences.  20:171-173. 1983
    1983 Enhancement of left ventricular function by glucose-insulin-potassium in acute myocardial infarctionAmerican Journal of Cardiology.  51:1041. 1983
    1983 A life table and Cox regression analysis of patients with combined proximal left anterior descending and proximal left circumflex coronary artery disease: Non-left main equivalent lesions (CASS)Circulation.  68:1163-1170. 1983
    1983 Cardiac catheterization and angiographic analysis computer applicationsProgress in Cardiovascular Diseases.  25:409-434. 1983
    1983 Combined aortic valve replacement and myocardial revascularization. Experience with a cold cardioplegic techniqueAnnals of Surgery.  197:721-727. 1983
    1983 Evaluation of a QRS scoring system for estimating myocardial infarct size. III. Correlation with quantitative anatomic findings for inferior infarctsAmerican Journal of Cardiology.  51:382-389. 1983
    1982 Costs and benefits associated with treatment for coronary artery diseaseCirculation.  66. 1982
    1982 Employment status after coronary artery bypass surgeryCirculation.  65. 1982
    1982 Enhancement of left ventricular function by glucose-insulin-potassium infusion in acute myocardial infarction.American Journal of Cardiology.  49:811-820. 1982
    1982 Advantages of the caudocranial left anterior oblique left ventriculogram in adult heart diseaseAmerican Journal of Cardiology.  49:369-380. 1982
    1982 Comparison of the cumulative survival among patient groups with a left main coronary artery lesion after surgical and therapeutic treatmentKardiologiia.  22:53-57. 1982
    1982 Detection of Myocardial Injury after Coronary Artery Bypass Grafting Using a Hypothermic, Cardioplegic TechniqueAnnals of Thoracic Surgery.  33:139-144. 1982
    1982 Epidemiologic study of candidates for coronary artery bypass surgeryCirculation.  66. 1982
    1982 Evaluation of a QRS scoring system for estimating myocardial infarct size. II. Correlation with quantitative anatomic findings for anterior infarctsAmerican Journal of Cardiology.  49:1604-1614. 1982
    1982 Glucose-insulin-potassium administration in acute myocardial infarction.Annual Review of Medicine.  33:375-383. 1982
    1982 Glucose-insulin-potassium infusion in acute myocardial infarction - results of a prospective randomized studyClinical research.  30. 1982
    1982 Quantitative axial oblique contrast left ventriculography: Validation of the method by demonstrating improved visualization of regional wall motion and mitral valve function with accurate volume determinationsAmerican Heart Journal.  103:185-194. 1982
    1982 The importance of angled right anterior oblique views in improving visualization of the coronary arteries. Part I: Caudocranial viewRadiology.  142:631-636. 1982
    1982 The importance of angled right anterior oblique views in improving visualization of the coronary arteries. Part II: Craniocaudal viewRadiology.  142:637-641. 1982
    1982 Total occlusion of the left main coronary artery: The Coronary Artery Surgery Study (CASS) experienceAmerican Journal of Cardiology.  49:2003-2010. 1982
    1982 Unstable angina pectoris: Is it time to change our approach?American Heart Journal.  103:154-156. 1982
    1981 Advances in the treatment of heart failureCardiovascular clinics.  11:49-64. 1981
    1981 Cardiogenic shockCardiovascular clinics.  11:15-24. 1981
    1981 Clinical interventions for the preservation of ischemic myocardiumCardiovascular clinics.  11:163-177. 1981
    1981 Clinical methods for assessment of myocardial infarct sizeCardiovascular clinics.  11:151-162. 1981
    1981 Current status of hemodynamic diagnoses, indications, diagnoses, complicationsCardiovascular clinics.  11:1-13. 1981
    1981 Management of unstable angina pectorisCardiovascular clinics.  11:65-70. 1981
    1981 New approaches to the diagnosis and management of acute cardiac failure.The Alabama journal of medical sciences.  18:268-273. 1981
    1981 Prehospital and initial hospital management of acute myocardial infarction.The Alabama journal of medical sciences.  18:255-258. 1981
    1981 Right ventricular infarction (author's transl)Revista Médica de Chile.  109:641-650. 1981
    1981 Advantage of the cranial-right anterior oblique view in diagnosing mid left anterior descending and distal right coronary artery diseaseAmerican Journal of Cardiology.  48:754-764. 1981
    1981 Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS)Circulation.  64:360-367. 1981
    1981 Clinical effects of glucose-insulin-potassium on left ventricular function in acute myocardial infarction: Results from a randomized clinical trialAmerican Heart Journal.  102:313-324. 1981
    1981 Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarctionAmerican Heart Journal.  102:1029-1037. 1981
    1981 Coronary revascularization surgery. Feasibility after myocardial infarctionPostgraduate Medicine.  69:36-49. 1981
    1981 Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease. Report of the collaborative study in coronary artery surgery (CASS)American Journal of Cardiology.  48:765-777. 1981
    1981 Glucose-insulin-potassium induced alterations in individual plasma free fatty acids in patients with acute myocardial infarctionAmerican Heart Journal.  102:10-15. 1981
    1981 Limited exercise testing soon after myocardial infarction. Correlation with early coronary and left ventricular angiographyAnnals of Internal Medicine.  94:727-734. 1981
    1981 Method for quantitative analysis of regional left ventricular function with first pass and gated blood pool scintigraphyAmerican Journal of Cardiology.  47:618-625. 1981
    1981 Modern approach to myocardial infarction: Determination of prognosis and therapyAmerican Heart Journal.  101:75-85. 1981
    1981 Right ventricular infarction and functionAmerican Heart Journal.  101:215-218. 1981
    1981 Significance of the caudal left-anterior-oblique view in analyzing the left main coronary artery and its major branchesRadiology.  139:39-43. 1981
    1981 Unstable angina pectoris: National cooperative study group to compare medical and surgical therapy. IV. Results in patients with left anterior descending coronary artery diseaseAmerican Journal of Cardiology.  48:517-524. 1981
    1980 Effects of vasodilators on renal function in severe heart failureNouvelle Presse Medicale.  9:2399-2403. 1980
    1980 Operative Risk Factors in Patients with Left Main Coronary-Artery DiseaseNew England Journal of Medicine.  303:953-957. 1980
    1980 Surgical vs nonsurgical management of patients after myocardial infarctionCirculation.  62. 1980
    1980 Myocardial damage in coronary artery bypass surgical patients anaesthetized with two anaesthetic techniques: a random comparison of halothane and enfluraneCanadian Anaesthetists' Society journal.  27:238-247. 1980
    1980 Coronary morphology in patients with unstable angina pectoris. Quantitative analysis of coronary angiograms before and after one year of medical treatmentHerz.  5:25-33. 1980
    1980 ANALYSIS OF 35-LEAD PRECORDIAL ELECTROCARDIOGRAPHIC MAPS.Computers in Cardiology.  335-338. 1980
    1980 Coronary angiography soon after myocardial infarctionChest.  77:58-64. 1980
    1980 Detection of residual jeopardized myocardium 3 weeks after myocardial infarction by exercise testing with thallium-201 myocardial scintigraphyCirculation.  61:729-737. 1980
    1980 Diabetic neuropathy of the heart and arteriesAmerican Journal of Cardiology.  45:475. 1980
    1980 Preservation of ischemic myocardium with glucose-insulin-potassium in patients with isolated left anterior descending stenosisAmerican Journal of Cardiology.  45:484. 1980
    1980 Prevalence of mural thrombi and systemic embolization with left ventricular aneurysm. Effect of anticoagulation therapyChest.  77:463-469. 1980
    1980 ReplyAmerican Journal of Cardiology.  46:178. 1980
    1980 Surgical versus medical therapy for treatment of unstable angina: Changes in work status and family incomeAmerican Journal of Cardiology.  45:134-140. 1980
    1980 Transient electrocardiographic changes in patients with unstable angina: Relation to coronary arterial anatomyAmerican Journal of Cardiology.  46:28-33. 1980
    1980 Unstable angina pectoris: National cooperative study group to compare surgical and medical therapy. III. Results in patients with S-T segment elevation during painAmerican Journal of Cardiology.  45:819-824. 1980
    1980 Use of glucose-insulin-potassium in treating myocardial infarctionJournal of Cardiovascular Medicine.  5:237-248. 1980
    1979 Unstable angina pectoris. An examination of modes and costs of therapyCirculation.  60. 1979
    1979 Use of blood-pool imaging in evaluation of diffuse activity patterns in technetium-99m pyrophosphate myocardial scintigraphyJournal of Nuclear Medicine.  20:496-501. 1979
    1979 Cardiogenic shock.Medical times.  107:33-38. 1979
    1979 Duration of action of isosorbide dinitrateChest.  75:2-4. 1979
    1979 Effect of filming projection and interobserver variability on angiographic biplane left ventricular volume determinationCirculation.  59:96-104. 1979
    1979 Emergency revascularization for acute myocardial infarction: An unproved experimental approachAmerican Journal of Cardiology.  44:1407-1409. 1979
    1979 Glucose-insulin-potassium infusion in acute myocardial infarction. Review of clinical experiencePostgraduate Medicine.  65:93-99. 1979
    1979 Impaired maximal rate of left ventricular relaxation in patients with coronary artery disease and left ventricular dysfunctionCirculation.  59:984-991. 1979
    1979 Incidence of new pulmonary perfusion defects after routine cardiac catheterizationAmerican Journal of Cardiology.  43:529-532. 1979
    1979 Medical or surgical therapy for unstable angina pectoris?The Journal of cardiovascular medicine.  4:1059-1074. 1979
    1979 Prospective randomized trial of glucose-insulin-potassium in acute myocardial infarction. Effects on myocardial hemodynamics, substrates and rhythmAmerican Journal of Cardiology.  43:801-809. 1979
    1979 Quantitative coronary arteriography. Coronary anatomy of patients with unstable angina pectoris reexamined 1 year after optimal medical therapyAmerican Journal of Cardiology.  43:699-707. 1979
    1979 Reduction of myocardial infarction scar with glucose-insulin-potassium in patients with isolated left anterior descending stenosisClinical research.  27. 1979
    1979 Unstable angina pectoris: A comparison of the costs of medical and surgical treatmentAmerican Journal of Cardiology.  44:112-117. 1979
    1979 Usefulness and limitations of thallium-201 myocardial scintigraphy in delineating location and size of prior myocardial infarctionCirculation.  59:1010-1019. 1979
    1978 Invited commentaryWorld Journal of Surgery.  2:697-698. 1978
    1978 Changes in left ventricular segmental wall motion following randomization to medicine or surgery in patients with unstable angina.Circulation.  58. 1978
    1978 Deep venous thrombosis of the upper extremity associated with use of the Swan-Ganz catheterChest.  73:673-675. 1978
    1978 Effect of glucose-insulin-potassium infusion during pacingCirculation.  58. 1978
    1978 Hemodynamic and metabolic effects of cigarette smoking in patients with coronary artery diseaseClinical research.  26. 1978
    1978 Hemodynamic and metabolic effects of intravenous digoxin in patients with coronary artery diseaseClinical research.  26. 1978
    1978 Influence of anticoagulation on the incidence of mural thrombi and systemic embolization in patients with left ventricular aneurysmsClinical research.  26. 1978
    1978 Intramitochondrial inclusions in the myocardial cells of human hearts with coronary diseaseJournal of Molecular and Cellular Cardiology.  10. 1978
    1978 Left ventricular aneurysmectomy in patients with single vs multivessel coronary artery disease.Circulation.  58. 1978
    1978 Metabolic support of mechanical performance in myocardial infarction. A randomized clinical trial of glucose-insulin-potassiumClinical research.  26. 1978
    1978 Relation of graded exercise test findings after myocardial infarction to extent of coronary artery disease and left ventricular dysfunctionAmerican Journal of Cardiology.  42:716-723. 1978
    1978 Renal response to vasodilator therapy in congestive heart failureClinical research.  26. 1978
    1978 Unstable angina pectoris: National cooperative study group to compare surgical and medical therapy. II. In-Hospital experience and initial follow-up results in patients with one, two and three vessel diseaseAmerican Journal of Cardiology.  42:839-848. 1978
    1978 Vasodilating effects of β-pyridylcarbinol in coronary artery diseaseClinical research.  26. 1978
    1977 Acute effects of glucose-insulin-potassium infusion on myocardial substrates, coronary blood flow and oxygen consumption in manAmerican Journal of Cardiology.  40:421-428. 1977
    1977 Coronary arterial surgery in patients with incapacitating angina pectoris and myxedemaAmerican Journal of Cardiology.  40:226-231. 1977
    1977 Correlation of angiographic estimates of myocardial infarct size and accumulated release of creatine kinase MB isoenzyme in manCirculation.  56:199-205. 1977
    1977 Effect of heparin-induced free fatty acid elevation on myocardial oxygen consumption in manAmerican Journal of Cardiology.  40:365-372. 1977
    1977 Evaluation of left ventricular function in patients with ischemic cardiomyopathy in response to L carnitine infusionClinical research.  25. 1977
    1977 Free fatty acids and arrhythmias following acute myocardial infarctionClinical research.  25. 1977
    1977 Improved outcome for prehospital cardiopulmonary collapse with resuscitation by bystandersCirculation.  56:901-905. 1977
    1977 Metabolic effects of glucose insulin potassium (GIK) infusion during acute myocardial infarction (AMI)Diabetes.  26. 1977
    1977 Modern approach to the patient with acute myocardial infarctionCurrent Problems in Cardiology.  1. 1977
    1977 ON-LINE COMPUTERIZED ASSESSMENT OF CORONARY SINUS BLOOD FLOW BY THERMODILUTION.Computers in Cardiology.  257-261. 1977
    1977 Quantitative assessment of ventricular performance in unstable ischemic heart disease by dextran function curvesCirculation.  55:858-863. 1977
    1977 Technetium 99m stannous pyrophosphate myocardial scintigraphy. Reliability and limitations in assessment of acute myocardial infarctionCirculation.  56:192-198. 1977
    1976 Glucose insulin potassium, free fatty acids and acute myocardial infarction in manCirculation.  53. 1976
    1976 Treatment of congestive heart failureCOMPR.THER..  2:24-32. 1976
    1976 Anginal threshold and glucose-insulin-potassium in unstable ischemic heart diseaseCirculation.  54. 1976
    1976 Changes in cardiac metabolism and coronary vascular hemodynamics associated with glucose insulin potassium infusion in manClinical research.  24. 1976
    1976 Effect of plasma free fatty acid level on myocardial oxygen consumption in manClinical research.  24. 1976
    1976 MEASUREMENT OF CARDIAC PARAMETERS FROM CARDIOVASCULAR IMAGES. 1976
    1976 Metabolic support of ventricular function in patients with myocardial infarction by an infusion of glucose insulin potassiumClinical research.  24. 1976
    1976 Randomized study of glucose insulin potassium in patients with acute myocardial infarctionClinical research.  24. 1976
    1976 Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusionAmerican Heart Journal.  92:441-454. 1976
    1976 SIMULTANEOUS ELECTROPHYSIOLOGIC AND HEMODYNAMIC COMPUTERIZED MONITORING. 1976
    1975 CATHETERIZATION AND ANGIOGRAPHIC ANALYSIS COMPUTER APPLICATIONS.Comput in Cardiol, Thoraxcentrum.  131-135. 1975
    1975 COMPUTERIZED HEMODYNAMIC AND ELECTROPHYSIOLOGIC CLINICAL STUDIES IN A MYOCARDIAL INFARCTION RESEARCH UNIT - FIVE YEARS EXPERIENCE.Comput in Cardiol, Thoraxcentrum.  95-99. 1975
    1975 Comparison of Indices of Muscle and Pump Performance in Patients with Coronary Artery DiseaseCatheterization and cardiovascular diagnosis.  1:17-34. 1975
    1975 Effect of glucose insulin potassium infusion on hospital mortality of acute myocardial infarctionClinical research.  23. 1975
    1975 Effects of glucose-insulin-potassium on myocardial substrate availability and utilization in stable coronary artery disease. Studies on myocardial carbohydrate, lipid and oxygen arterial-coronary sinus differences in patients with coronary artery diseaseAmerican Journal of Cardiology.  36:929-937. 1975
    1975 Effects of glucose-insulin-potassium on myocardial substrate availability and utilization in stable coronary artery disease. Studies on myocardial carbohydrate, lipid and oxygen arterial-coronary sinus differences in patients with coronary artery diseaseAmerican Journal of Cardiology.  36:929-937. 1975
    1975 Effects of heparin induced free fatty acid elevation on cardiac metabolism, rhythm, and mechanical performance in patients with stable coronary artery diseaseClinical research.  23. 1975
    1975 Heparin induced free fatty acid elevation in patients with coronary artery diseaseClinical research.  23. 1975

    Principal Investigator On

  • Private Grant  awarded by AMGEN, INC. 2016 - 2024
  • Private Grant  awarded by AMGEN, INC. 2012 - 2020
  • HPS 3/TIMI 55: REVEAL (Randomized EValuation of the Effects of Anacetrapib through Lipid-modification)  awarded by Brigham and Women's Hospital 2011 - 2019
  • Private Grant  awarded by EISAI, INC. 2014 - 2018
  • Private Grant  awarded by Sanofi US Services Inc 2013 - 2018
  • Private Grant  awarded by AMGEN, INC. 2015 - 2017
  • Private Grant  awarded by AMGEN, INC. 2011 - 2017
  • Private Grant  awarded by AMGEN, INC. 2013 - 2017
  • Private Grant  awarded by ELI LILLY AND COMPANY 2012 - 2016
  • PEGASUS:A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events with Ticagrelor Compared to Placebo on Background of Acetyl Salicylic Acid (ASA) Therapy in Patients with History of Myocardial Infarction  awarded by Brigham and Women's Hospital 2011 - 2015
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2005 - 2015
  • SOLID TIMI 52: Stabilization of Plaques Using Darapladib--A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events  awarded by Brigham and Women's Hospital 2010 - 2014
  • Private Grant  awarded by AMGEN, INC. 2012 - 2014
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd. 2010 - 2014
  • SAVOR: Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus. A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IV Trial To Evaluate the Effect of Saxagliptin on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischaemic Stoke in Patients with Type 2 Diabetes  awarded by Brigham and Women's Hospital 2010 - 2013
  • ELEVATE-TIMI 56: Escalating Clopidogrel by Involving a Genetic Strategy  awarded by Brigham and Women's Hospital 2010 - 2013
  • Private Grant  awarded by ELI LILLY AND COMPANY 2008 - 2013
  • HPS 3/TIMI 55-Reveal (Randomized Evaluation of the Effects of Anacetrapib through Lipid-Modification)  awarded by Brigham and Women's Hospital 2011 - 2012
  • Private Grant  awarded by SCHERING PLOUGH CORPORATION 2007 - 2012
  • Private Grant  awarded by AMGEN, INC. 2011 - 2012
  • Private Grant  awarded by Genentech 2012
  • Private Grant  awarded by JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, LLC 2008 - 2012
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2007 - 2011
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2009 - 2011
  • Private Grant  awarded by ASTRAZENECA INTERNATIONAL 2004 - 2011
  • Women's Ischemia Syndrome Evaluation National Death Index (WISE NDI)  awarded by University of Pittsburgh 2009 - 2010
  • Education And Training

  • Doctor of Medicine, Johns Hopkins University 1969
  • Certificate in Medicine, Princeton University 1965
  • Johns Hopkins Hospital, Internship 1970
  • Johns Hopkins Hospital, Residency 1971
  • UAB Hospital, Postdoctoral Fellowship 1975
  • Full Name

  • William Rogers